Merck signs up to $3.3 bln cancer drug deal with China-based LaNova
Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...
Eli Lilly announces results from Phase 3 SURMOUNT-1 three-year study
Eli Lilly (LLY) and Company announced detailed results from the Phase 3 SURMOUNT-1 three-year study, the longest completed study to date of ...
Ibj.com20h
Lilly expands research in Singapore with focus on sleep quality
Eli Lilly and Co. plans to set up a $31 million digital health innovation hub in Singapore, expanding its research and ...
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...